Markets

Home  /  Investors   /  Press releases

Press releases

Here you will find all press releases from XVIVO.

Showing 1 to 23 out of 23 posts.
7 Dec, 2018
Professor Stig Steen’s heart preservation technology required for successful transplantation from pigs to baboons
26 Oct, 2018
XVIVO Perfusion AB (publ) Interim Report January – September 2018
17 Oct, 2018
Conference call on Interim Report
24 Sep, 2018
Nomination Committee of XVIVO Perfusion AB (publ)
20 Jul, 2018
Interim report January-June 2018
12 Jul, 2018
Conference call on Interim Report
29 Jun, 2018
Change in number of shares and votes in XVIVO Perfusion
25 Jun, 2018
Perfadex Plus approved by the FDA
14 Jun, 2018
XVIVO Perfusion changes the date of reporting of the interim report January – June 2018 to July 20, 2018
12 Jun, 2018
UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE
5 Jun, 2018
XVIVO Perfusion launches Perfadex Plus, an upgraded ready to use version of Perfadex
14 May, 2018
Positive findings in the PrimECC study
11 May, 2018
PMA application for XPS™ with STEEN Solution™ submitted to the FDA
27 Apr, 2018
Report from Annual general meeting of XVIVO Perfusion AB (publ)
26 Apr, 2018
XVIVO Perfusion AB (publ) Interim Report January – March 2018
19 Apr, 2018
Conference call on Interim Report
4 Apr, 2018
Annual Report 2017
22 Mar, 2018
Annual General Meeting of XVIVO Perfusion AB (publ)
22 Mar, 2018
Option program for the CEO and the deputy CEO
8 Mar, 2018
Information from XVIVO Perfusion´s Nomination Committee
9 Feb, 2018
XVIVO Perfusion AB (publ) Report on Operations 2017
5 Feb, 2018
Date changed for Conference call on Report on Operations
1 Feb, 2018
Conference call on Report on Operations

Fill out the form to watch the video